Heally

Medications offered

As listed on the provider’s own site. Whether a product is FDA-approved or compounded is the single most important distinction here — we explain why.

• Oral semaglutideType not stated
• TirzepatideType not stated
• MetforminFDA-approved

What they publish

Heally publishes 2 of 12 standard terms. Fields marked “not publicly disclosed” were not stated on the pages we captured, and we have not filled those gaps with assumptions. Compare disclosure across providers

Membership / programme fee

Tirzepatide published from $299/month as a new-patient offer; oral semaglutide from $149/month; metformin from about $49/month; a $250/month figure also published (as published)

Medication cost

Not publicly disclosed on the pages we captured.

Introductory offer

Not publicly disclosed on the pages we captured.

Insurance

States coverage for GLP-1 medications varies by plan, indication and dose, and offers transparent self-pay pricing as the alternative.

HSA / FSA

Not publicly disclosed on the pages we captured.

Consultation process

Not publicly disclosed on the pages we captured.

Eligibility

Not publicly disclosed on the pages we captured.

Lab work

Not publicly disclosed on the pages we captured.

Pharmacy fulfilment

Not publicly disclosed on the pages we captured.

Shipping

Not publicly disclosed on the pages we captured.

Support services

Not publicly disclosed on the pages we captured.

Cancellation

Not publicly disclosed on the pages we captured.

Refunds

Not publicly disclosed on the pages we captured.

What stands out

• Names metformin at around $49/month alongside the GLP-1 options. Metformin is a long-established, inexpensive medication and most GLP-1 sellers do not mention it at all.
• States plainly that coverage varies by plan, indication and dose rather than implying coverage is likely.

Questions to ask before you pay

These are things we could not settle from published pages, or that we think are easy to misread. Get answers in writing.

• Metformin and a GLP-1 are very different treatments — discuss which is appropriate with a clinician rather than choosing on price.
• Ask whether the semaglutide or tirzepatide is FDA-approved or compounded.